Evidence map›Paper›PMID 31703057›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2019

Overexpression of Tripartite Motif-Containing 48 (TRIM48) Inhibits Growth of Human Glioblastoma Cells by Suppressing Extracellular Signal Regulated Kinase 1/2 (ERK1/2) Pathway.

Li-Ping Xue, Bin Lu, Bi-Bo Gao, Yang-Yang Shi, Jing-Qi Xu, Rui Yang, Bo Xu, Peng Ding

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Multifaceted role ofMedComm · 2024
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Li-Ping XueDepartment of Ophthalmology, Yunnan No. 2 Provincial People's Hospital, Kunming, Yunnan, China (mainland).
Bin LuDepartment of Neurosurgery, HuZhou Central Hospital, Huzhou, Zhejiang, China (mainland).
Bi-Bo GaoDepartment of Neurosurgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China (mainland).
Yang-Yang ShiDepartment of Neurosurgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China (mainland).
Jing-Qi XuDepartment of Neurosurgery, Xi'an DaXing Hospital, Xi'an, Shaanxi, China (mainland).
Rui YangDepartment of Neurosurgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China (mainland).
Bo XuDepartment of Neurosurgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China (mainland).
Peng DingDepartment of Neurosurgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China (mainland).
Kunming Medical University · CNFirst Affiliated Hospital of Kunming Medical University · CNHuzhou Central Hospital · CNSecond People's Hospital of Yunnan Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Herein, we found that tripartite motif-containing 48 (TRIM48) was reduced in human glioblastoma (GBM) cell lines. We investigated whether and how TRIM48 functions in human GBM in vitro. MATERIAL AND METHODS Human GBM cells (U87 MG and U138 MG) were infected with lentivirus to overexpress TRIM48, and 1 human GBM cell line (T98G) was infected with siRNAs to knock down TRIM48 expression. Techniques used included cell proliferation assay, measured by CCK-8 and BrdU-ELISA method, and cell cycle assay, determined using flow cytometry. Curcumin, a specific activator of extracellular signal regulated kinases (ERK1/2), or PD98059, a specific inhibitor of ERK1/2, was used to activate or block the ERK1/2 pathway, respectively. Expression of phosphorylated (p)-ERK1/2, and its downstream targets (Cyclin D1) were measured to assess the mechanism. RESULTS Our data suggest that overexpression of TRIM48 reduces the viability of U87 MG and U138 MG and leads to cell cycle arrest (in G0-G1 phase), which is associated with blockade of the ERK1/2 pathway and reduction of Cyclin D1. In contrast, knockdown of TRIM48 resulted in the opposite effects. Interestingly, the inhibitory effect of TRIM48 overexpression on human GBM cell growth and the inactivation of ERK1/2 were significantly alleviated with additional curcumin treatment, while it the promoted the effect of siTRIM48 on human GBM cell growth, and the activation of ERK1/2 was significantly alleviated with additional PD98059 treatment. CONCLUSIONS TRIM48 suppressed the growth of human GBM cell via the prevention of ERK1/2 activation.

Indexed as

Carrier ProteinsCell CycleCell Cycle CheckpointsCell DivisionCell Line, TumorCell ProliferationCurcuminExtracellular Signal-Regulated MAP KinasesFlavonoidsGlioblastomaHumansMAP Kinase Signaling SystemMitogen-Activated Protein Kinase 32-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneCarrier ProteinsCurcuminExtracellular Signal-Regulated MAP KinasesFlavonoidsMitogen-Activated Protein Kinase 3TRIM49 protein, human

Identifiers

PMID31703057
PMCPMC6858785
OpenAlexW2989534291

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.